Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 14Gastrointestinal 7Head & Neck 3Genitourinary 3Sarcoma 2Tumor-Agnostic 1Other solid neoplasm 1Gynecologic 1Endocrine 1Breast 1

Conditions

Thyroid Cancer, Papillary 1Carcinoma, Medullary 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ferrosoferric Oxide × Endocrine × Clear all
NCT01927887 2017-06-06

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Massachusetts General Hospital

Phase NA Completed
12 enrolled 6 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡